158 related articles for article (PubMed ID: 10601066)
1. Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis.
Girgrah N; Liu P; Collier J; Blendis L; Wong F
Gut; 2000 Jan; 46(1):114-20. PubMed ID: 10601066
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis.
Wong F; Liu P; Blendis L
Hepatology; 2002 Jun; 35(6):1449-58. PubMed ID: 12029630
[TBL] [Abstract][Full Text] [Related]
3. Sodium homeostasis with chronic sodium loading in preascitic cirrhosis.
Wong F; Liu P; Blendis L
Gut; 2001 Dec; 49(6):847-51. PubMed ID: 11709521
[TBL] [Abstract][Full Text] [Related]
4. Effects of ursodeoxycholic acid on systemic, renal and forearm haemodynamics and sodium homoeostasis in cirrhotic patients with refractory ascites.
Wong F; Bomzon A; Allard J; Liu P; Blendis L
Clin Sci (Lond); 1999 May; 96(5):467-74. PubMed ID: 10209078
[TBL] [Abstract][Full Text] [Related]
5. The renal sympathetic and renin-angiotensin response to lower body negative pressure in well-compensated cirrhosis.
Wong F; Sniderman K; Blendis L
Gastroenterology; 1998 Aug; 115(2):397-405. PubMed ID: 9679045
[TBL] [Abstract][Full Text] [Related]
6. One-week losartan administration increases sodium excretion in cirrhotic patients with and without ascites.
Yang YY; Lin HC; Lee WC; Hou MC; Lee FY; Chang FY; Lee SD
J Gastroenterol; 2002; 37(3):194-9. PubMed ID: 11931532
[TBL] [Abstract][Full Text] [Related]
7. Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis.
Helmy A; Jalan R; Newby DE; Hayes PC; Webb DJ
Gastroenterology; 2000 Mar; 118(3):565-72. PubMed ID: 10702208
[TBL] [Abstract][Full Text] [Related]
8. Chronic administration of losartan, an angiotensin II receptor antagonist, is not effective in reducing portal pressure in patients with preascitic cirrhosis.
Tripathi D; Therapondos G; Lui HF; Johnston N; Webb DJ; Hayes PC
Am J Gastroenterol; 2004 Feb; 99(2):390-4. PubMed ID: 15046234
[TBL] [Abstract][Full Text] [Related]
9. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity.
Wong F; Logan A; Blendis L
Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419
[TBL] [Abstract][Full Text] [Related]
10. Activation of RAAS in a rat model of liver cirrhosis: no effect of losartan on renal sodium excretion.
Fialla AD; Schaffalitzky de Muckadell OB; Bie P; Thiesson HC
BMC Nephrol; 2018 Sep; 19(1):238. PubMed ID: 30231858
[TBL] [Abstract][Full Text] [Related]
11. The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis.
Therapondos G; Hol L; Benjaminov F; Wong F
Hepatology; 2006 Sep; 44(3):640-9. PubMed ID: 16941706
[TBL] [Abstract][Full Text] [Related]
12. Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure.
Jalan R; Hayes PC
Gut; 2000 Apr; 46(4):527-33. PubMed ID: 10716683
[TBL] [Abstract][Full Text] [Related]
13. Role of angiotensin in renal sympathetic activation in cirrhotic rats.
Voigt MD; Jones SY; DiBona GF
Am J Physiol; 1999 Aug; 277(2):F245-50. PubMed ID: 10444579
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis.
Domenicali M; Caraceni P; Giannone F; Pertosa AM; Principe A; Zambruni A; Trevisani F; Croci T; Bernardi M
Gastroenterology; 2009 Jul; 137(1):341-9. PubMed ID: 19208344
[TBL] [Abstract][Full Text] [Related]
15. Renal sodium handling and neurohumoral systems in patients with cirrhosis in sitting posture: effects of spironolactone and water immersion.
Gerbes AL; Pilz A; Wernze H; Jüngst D
Clin Investig; 1993 Nov; 71(11):894-7. PubMed ID: 7906160
[TBL] [Abstract][Full Text] [Related]
16. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis.
Wong F; Liu P; Lilly L; Bomzon A; Blendis L
Clin Sci (Lond); 1999 Sep; 97(3):259-67. PubMed ID: 10464050
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide mediates the reduced vasoconstrictor response to angiotensin II in patients with preascitic cirrhosis.
Helmy A; Newby DE; Jalan R; Johnston NR; Hayes PC; Webb DJ
J Hepatol; 2003 Jan; 38(1):44-50. PubMed ID: 12480559
[TBL] [Abstract][Full Text] [Related]
18. Pattern of sodium handling and its consequences in patients with preascitic cirrhosis.
Wong F; Liu P; Allidina Y; Blendis L
Gastroenterology; 1995 Jun; 108(6):1820-7. PubMed ID: 7768388
[TBL] [Abstract][Full Text] [Related]
19. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
Schneider AW; Kalk JF; Klein CP
Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
[TBL] [Abstract][Full Text] [Related]
20. Natriuretic and aquaretic effects of intravenously infused calcium in preascitic human cirrhosis: physiopathological and clinical implications.
Sansoè G; Wong F
Gut; 2007 Aug; 56(8):1117-23. PubMed ID: 17303596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
